Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “AOP ORPHAN PHARMACEUTICALS AG [AT]”

4 pharma patents match "AOP ORPHAN PHARMACEUTICALS AG [AT]" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "AOP ORPHAN PHARMACEUTICALS AG [AT]" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “AOP ORPHAN PHARMACEUTICALS AG [AT]” · 30,257 patents in full index Clear search

  1. EP 2988750

    VERWENDUNG VON LANDIOLOLHYDROCHLORID BEI DER LANGZEITBEHANDLUNG VON TACHYARRHYTHMIEN

    AOP ORPHAN PHARMACEUTICALS AG [AT] · Granted Mar 2, 2016 · Expires Feb 26, 2036

    granted
  2. AU 2013258031

    Parenteral esmolol formulation

    AOP ORPHAN PHARMACEUTICALS AG [AT] · Granted Nov 20, 2014 · Expires Nov 15, 2034

    granted
  3. AU 2009324043

    Novel composition for treatment of essential thrombocythemia

    AOP ORPHAN PHARMACEUTICALS AG [AT] · Granted Jun 10, 2010 · Expires Jun 5, 2030

    granted
  4. AU 2008340179

    Pharmaceutical composition for the parenteral administration of ultrashort-effective beta-adrenoreceptor antagonists

    AOP ORPHAN PHARMACEUTICALS AG [AT] · Granted Jul 2, 2009 · Expires Jun 27, 2029

    granted